United States

Mauna Kea Technologies SAS (MKEA.PA)

MKEA.PA on Paris Stock Exchange

2 Dec 2016
Change (% chg)

€-0.06 (-1.94%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for MKEA.PA


Mauna Kea Technologies SAS, also known as Mauna Kea Technologies SA, is a France-based company active in the healthcare business sector. It specializes in designing, developing, and selling medical imaging tools and systems. The Company’s products, used mainly in endoscopy, are intended for viewing and detecting deficiencies in... (more)


Beta: 0.78
Market Cap(Mil.): €62.07
Shares Outstanding(Mil.): 19.16
Dividend: --
Yield (%): --


  MKEA.PA Industry Sector
P/E (TTM): -- 46.95 29.87
EPS (TTM): -0.63 -- --
ROI: -64.27 7.26 14.95
ROE: -77.85 9.04 16.29

BRIEF-Mauna Kea Technologies secures equity financing facility

* Mauna Kea Technologies secures an equity financing facility to support its development

Nov 17 2016

BRIEF-Mauna Kea Technologies gives update on cellvizio's efficacy

* Cellvizio's strong clinical efficacy in the prevention of certain pancreatic cancers confirmed by positive results from contact study presented at UEGW 2016

Oct 20 2016

BRIEF-Mauna Kea Technologies announces launch of study on cellvizio in pediatric cardiac surgery

* Announces launch of first study on cellvizio in pediatric cardiac surgery Source text for Eikon: Further company coverage: (Gdynia Newsroom:)

Oct 12 2016

BRIEF-Mauna Kea technologies reports H1 2016 financial results

* H1 revenue 4.9 million euros ($5.47 million) versus 4.7 million euros year ago

Sep 21 2016

BRIEF-Mauna Kea announces capital increase of about 4.4 mln euros

* Announced on Tuesday capital increase of about 4.4 million euros ($4.9 million)

Jul 13 2016

BRIEF-Mauna Kea Technologies Q2 sales rise to 2.5 million euros

* Q2 sales EUR 2.5 million ($2.77 million) versus EUR 2.2 million year ago

Jul 12 2016

Earnings vs. Estimates